Anti-tau VHH therapy against PHF6: a safe approach to slowing the phenotype of tau pathology

Caillierez R, Leboullenger C, Leclercq S, Besegher M, Begard S, Auger F, Maurage CA, Accart B, Mortelecque J, Dupre E, Danis C, Landrieu I, Buee L, Colin M.